POPULARITY
In this episode of Microbiome Medics Podcast, I (Dr. Sheena Fraser) speak with Dr. Holly Wilkinson, a microbiome scientist at Hull York Medical School, about the vital role of the skin microbiome in health and disease. We discuss how the skin microbiome's unique characteristics, influenced by factors like body location and hygiene, are crucial for maintaining skin health. Dr. Wilkinson explains the relationship between the skin barrier and microbiota and the implications for conditions like acne and eczema.We also explore natural skincare options, the research on probiotics for wound healing, and her current studies on chronic wounds, emphasising microbiome composition as a predictor for healing outcomes. This engaging conversation underscores the importance of a holistic approach to skincare and the need for more awareness of microbiome science in clinical practice.This podcast is brought to you in collaboration with the British Society of Lifestyle Medicine.Disclaimer:The content in this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast.
Looking for the latest research in skin substitutes? You're in luck. Join Dr. Robert Kirsner as he discusses CAMPs or cellular, acellular, and matrix products. Learn about their application for chronic wounds, ulcers, conditions such as HS, and how you can use them in your clinic. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Robert Kirsner, MD PHD is Chairman and the endowed Harvey Blank Professor in the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Professor of Public Health Sciences at the University of Miami Miller School of Medicine. He is Chief of Dermatology at the University of Miami Hospital and Clinics and Jackson Memorial Hospital and directs the University of Miami Hospital Wound Center. His research interests include Wound Healing and Skin Cancer Epidemiology. Dr. Kirsner serves as one of 3 academic editors for the journal Wound Repair and Regeneration and on the editorial boards for a number of other journals in dermatology and wound healing. Dr. Kirsner serves in national leadership positions in both Wound Healing and Dermatology, including being Vice President of the American Academy of Dermatology and serving on the Wound Healing Society Board of Directors. Sponsored by University of Miami Visit University of Miami's website for more information.
Chronic wounds can be challenging to live with, but with the right knowledge and treatment, they can be effectively managed and cured. Hyperbaric Oxygen Therapy uses pressurized oxygen to promote tissue repair and reduce inflammation, making it an effective option for chronic wounds and non-healing injuries. Learn about how wounds develop and treatment options from Scott Zittel, D.O., Medical Director of Enloe Health's Wound/Ostomy & Hyperbaric Center.
What can be done to improve clinical trials for patients with chronic wounds? In this new episode of the Scope of Things, host Deborah Borfitz speaks with Dr. Caroline Fife, world-renowned wound care physician and Chief Medical Officer at Intellicure, about the clinical realities of chronic wounds and wound treatment. Dr. Fife shares her thoughts on the “sorry state” of clinical trials for wound care products and what she has learned as the Executive Director of the U.S. Wound Registry that shed some light on the matter. She also discusses how her first clinical trial sparked her drive to improve conditions and the barriers that prevent innovation in the development of new products and technology. Links from this episode: Clinical Research News Scope Summit Intellicure
Priyanka Dutta-Passecker is the CEO and Founder of Healiva, a Swiss start-up focused on innovative treatments for acute and chronic wounds. Healiva begins the process by cleaning the wound using an enzyme invented by Priyanka. Depending on the severity of the wound, autologous or allogeneic cell therapy is used to make new skin to heal the wound. Priyanka explains, "So, to give a background for when we talk about personalized cell therapies and autologous cell therapy. We take a patient here, and from the patient, we make the patient's skin. That means that we're completely personalizing and making the skin of the patient. And this is given to extremely chronic non-healing wound patients like venous leg ulcer patients or diabetic foot ulcer patients. The skin gets integrated on their ulcer and closes the ulcer. That's one of our autologous cell therapy products called Epidex." "We do keep the primary cells when we take the hair follicle. As you may know, hair follicles are epithelial cells that we expand, and we keep the cells. And when they come back, we can make the full skin, the epidermis differentiation, within two weeks. But generally, it takes four weeks. And it's given to the patient once it's ready within four to five days." "So, just to elaborate on what we mean by allogeneic cell therapy. So quite different from the autologous one, in allogenic cell therapy, we are taking healthy skin cells from you and me. We expand the skin cells, and we give the skin cells to the patient. What happens is that it releases growth factors which help in the healing. And there is no rejection because, of course, the cells do not stay on the wounds of the patient." #Healiva #WoundCare #PatientCare #SwissStartups #CellTherapy #ChronicWounds #RegenerativeMedicine #Diabetes #Healthtech healiva.com Download the transcript here
Priyanka Dutta-Passecker is the CEO and Founder of Healiva, a Swiss start-up focused on innovative treatments for acute and chronic wounds. Healiva begins the process by cleaning the wound using an enzyme invented by Priyanka. Depending on the severity of the wound, autologous or allogeneic cell therapy is used to make new skin to heal the wound. Priyanka explains, "So, to give a background for when we talk about personalized cell therapies and autologous cell therapy. We take a patient here, and from the patient, we make the patient's skin. That means that we're completely personalizing and making the skin of the patient. And this is given to extremely chronic non-healing wound patients like venous leg ulcer patients or diabetic foot ulcer patients. The skin gets integrated on their ulcer and closes the ulcer. That's one of our autologous cell therapy products called Epidex." "We do keep the primary cells when we take the hair follicle. As you may know, hair follicles are epithelial cells that we expand, and we keep the cells. And when they come back, we can make the full skin, the epidermis differentiation, within two weeks. But generally, it takes four weeks. And it's given to the patient once it's ready within four to five days." "So, just to elaborate on what we mean by allogeneic cell therapy. So quite different from the autologous one, in allogenic cell therapy, we are taking healthy skin cells from you and me. We expand the skin cells, and we give the skin cells to the patient. What happens is that it releases growth factors which help in the healing. And there is no rejection because, of course, the cells do not stay on the wounds of the patient." #Healiva #WoundCare #PatientCare #SwissStartups #CellTherapy #ChronicWounds #RegenerativeMedicine #Diabetes #Healthtech healiva.com Listen to the podcast here
Silicone-based wound dressings made with SILPURAN® from WACKER SILICONES are a much gentler alternative for treating chronic wounds, especially in older people. Thanks to their unique properties, these bandages prevent the dressing from sticking to the wound, allowing them to be removed with significantly less pain. Plus, they also ensure ideal conditions for healing wounds.
In this episode of The PODdoctors podcast, Dr. Damien Dauphinee, a board-certified foot and ankle surgeon, and Dr. Raafae Hussain, fellowship trained foot and ankle surgeon, talk about the common chronic wounds or ulcers they see every day, particularly diabetic foot ulcers, and how to treat them.“Probably the most common that we'll see is your neuropathic, aka your diabetic, foot ulcer. This is when you have uncontrolled diabetes, you have that neuropathy, you have that poor healing potential, and they end up walking until they get a sore, typically on the bottom of their foot, on a high-pressure spot. These are things we're able to take care of if we stay ahead of it.” - Dr. Raafae Hussain [04:51]“It's probably more important to get rid of the dead tissue, the broken-down collagen in the wound bed, than it is to use a silver dressing to prevent infection.” - Dr. Damien Dauphinee [18:23]“Every day a wound is open, especially in diabetic patients, is another chance for that to get infected. So, we really need to use whatever advanced therapy that we can get ahold of to get that wound closed rapidly because the expenses in these wounds are not in the stuff we're using to treat them. The expensive stuff is the amputation, the six weeks of antibiotics, the 3-4 trips to the hospital.” - Dr. Damien Dauphinee [22:40]Top Takeaways:4 major types of chronic wounds Methods of treating and dressing diabetic foot ulcersSantyl vs. Silver dressings: Which is better?How to offload diabetic foot ulcers to facilitate healingCan you reverse neuropathy in diabetic patients?Treating vascular and venous issues in patients with foot ulcersKey methods and biologics used in treating chronic woundsWhat You Will Learn:[00:39] Intro[02:07] Common wounds we see on a daily basis & Their causes[07:56] Diagnosing and treating ulcers on the feet[15:19] Dressing foot ulcers after the first treatment[23:33] Offloading diabetic foot ulcers[26:47] Important data & statistics on diabetic foot ulcers[28:46] Why podiatrists work with vascular specialists[36:04] Using hyperbaric oxygen therapy and NPWT to heal wounds[46:33] Biologics used for treating wounds[52:19] Important takeaways on chronic wounds in diabetic patients[57:23] Breaking down a few of Dr. Dauphinee's past chronic wound casesResources:Visit our website: https://thepoddoctors.comBook Mentioned: Saving Limbs, Saving Lives: Advanced Treatments for Preventing Amputations in Diabetic Populations by Dr. Damien DauphineeLearn more about the Wise Healing Center in Argyle, TX: https://www.wisehealthsystem.com/location/wise-healing-center-argyle
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38216]
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38216]
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38216]
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38216]
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38216]
What if we could trick stem cells into thinking they were young again? What would the impact be on human health and aging? Shiri Gur-Cohen, Ph.D., shares her work. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38216]
What challenges does aging pose to both individuals and society at large? What causes aging at the cellular and molecular level? Stem cell research is be key to finding solutions that increase our healthspan and change how we think about aging. Robert A.J. Signer, Ph.D., shares what is on the horizon. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38215]
What challenges does aging pose to both individuals and society at large? What causes aging at the cellular and molecular level? Stem cell research is be key to finding solutions that increase our healthspan and change how we think about aging. Robert A.J. Signer, Ph.D., shares what is on the horizon. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38215]
What challenges does aging pose to both individuals and society at large? What causes aging at the cellular and molecular level? Stem cell research is be key to finding solutions that increase our healthspan and change how we think about aging. Robert A.J. Signer, Ph.D., shares what is on the horizon. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38215]
What challenges does aging pose to both individuals and society at large? What causes aging at the cellular and molecular level? Stem cell research is be key to finding solutions that increase our healthspan and change how we think about aging. Robert A.J. Signer, Ph.D., shares what is on the horizon. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38215]
What challenges does aging pose to both individuals and society at large? What causes aging at the cellular and molecular level? Stem cell research is be key to finding solutions that increase our healthspan and change how we think about aging. Robert A.J. Signer, Ph.D., shares what is on the horizon. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38215]
What challenges does aging pose to both individuals and society at large? What causes aging at the cellular and molecular level? Stem cell research is be key to finding solutions that increase our healthspan and change how we think about aging. Robert A.J. Signer, Ph.D., shares what is on the horizon. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 38215]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Can we leverage stem cells to help live longer, healthier lives? Robert A.J. Signer, Ph.D., and Shiri Gur-Cohen, Ph.D., examine the process of aging at the molecular and cellular level to show how stem cells may be the key to preventing age-related health problems. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37968]
Kyle Quinn, assistant professor of biomedical engineering, discusses his research using multiphoton microscopy to create 3D images of tissue and explain how cell metabolism changes during the healing process of chronic wounds.
Dr. Ricardo Duran and Debra Gonzalez, Wellstar North Fulton Wound Care & Hyperbaric Center (North Fulton Business Radio, Episode 473) Medical Director Dr. Ricardo Duran and Program Director Debra Gonzalez joined North Fulton Business Radio host John Ray to discuss their work at Wellstar North Fulton Wound Care & Hyperbaric Center. This center recently received […] The post Dr. Ricardo Duran and Debra Gonzalez, Wellstar North Fulton Wound Care & Hyperbaric Center appeared first on Business RadioX ®.
Dr. Rivelino Montenegro is an engineer, scientist and serial entrepreneur. He has led companies and international scientific projects in countries such as Germany, Switzerland, USA, Brazil, and Canada. He has also written books and given lectures in many countries and holds a PhD in Chemistry from the prestigious Max-Planck Institute in Germany. Dr. Montenegro is the co-founder and managing director of Monarch Bio Implants, a Swiss Biotech start-up developing technologies for prostate cancer patients.On this episode, he shares how he became an entrepreneur in Canada and experienced major failures and pushbacks. God used him in a mighty way and Rivelino grew stronger in faith. He learned powerful spiritual lessons - and after trying and failing many times, he eventually experienced success on an entrepreneurial level. In 2020, his company Monarch Bioimplants received an investment of $23 million.Listen to his personal story and learn more about his newest inventions and products! Get in touch with Dr. Rivelino Montenegro below:His websiteHis company Are you getting our biweekly posts on how to combine faith & business? Get 3 powerful tips every other Tuesday! Click here to join.
Ken talks with Dr. Allan Caudill, Certified Wound Specialist Physician at Bronson See omnystudio.com/listener for privacy information.
When you have a wound, you know what usually happens: you clean it, treat it to prevent infection, and wait for it to heal on its own. But for some people, their wounds don't heal in this straightforward manner - instead, they experience prolonged pain, and the wounds constantly produce pus and even a foul smell. Is amputation the only way out, or is there hope for treating these hard-to-heal wounds? We find out from wound care practitioner Dato' Dr RS Kumar.Image credit: Shutterstock
Robert J. Klein, DPM, FACFAS, CWS (Glasgow) and Catherine T. Milne, MSN, APRN, ANP/ACNS, CWOCN-AP will list the most common wounds encountered in the post-acute setting and challenges with managing wounds in this setting, and examine patient-centered innovations for comprehensive wound care management in the post-acute settingTo view program information/faculty disclosures and claim your CE credit after the session, visit centerforhealingsolutions.com/podcasts.
In this episode, Ayesha talks about new revelations about how Johnson & Johnson funded studies in the early 1970s that involved injecting prisoners in a Pennsylvania jail, most of whom were Black, with asbestos. The company wanted to compare the effects of asbestos versus talc, one of the main ingredients in Johnson & Johnson's baby powder, on the skin. The company says it regrets backing the human asbestos experiments but says such human testing was common back then. The editorial team discussed Johnson & Johnson's ongoing legal battles over its baby powder and how it could have better handled the recent revelations by not having made excuses for the asbestos studies.The editorial team also discussed a new medical imaging device from Swift Medical for digital wound care and other skin conditions. The device fits on top of the camera of a cell phone and uses advanced imaging technology to capture “beneath-the-skin” images of the skin. Swift Medical says the device was designed to make wound care accessible for all patients, regardless of skin type and at any beside or clinical location. The images can be accessed by healthcare providers through an accompanying phone app to allow for remote monitoring and care. The team discussed the significant prevalence of chronic wounds, particularly associated with chronic conditions like diabetes, and how the device offers a great means of accessing information and care right from a cell phone. Read the full articles here: Johnson & Johnson Remorseful Over Funding Human Asbestos Experiments, But Says They Were Common in the PastSwift Medical Reveals New Imaging Device for Remote, Digital Wound CareFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Dr. Rountree and Kristi review a study from June 2021 in which they tested the effectiveness of laser therapy with wound dressing vs only wound dressing for chronic wound healing. Chronic wounds include chronic ulcers, post-operative infections, diabetic foot ulcers, bedsores, severe burns, venous leg ulcers, and traumatic wounds. These are difficult to manage and often lead to amputation. Hear about the laser settings and treatment protocols used and the results achieved.We have begun live-streaming this podcast. Watch this episode on Facebook and see the next episode LIVE in two weeks!Studies mentioned in this episodeClinical effects of high-intensity laser therapy on patients with chronic refractory wounds: a randomized controlled trial. YouTube ChannelLaser Therapy InstituteFurther Resources:Success with Laser Therapy Flowchart & Checklist InfographicCheck out these FREE Provider ResourcesRead about laser research on the LTI BlogLearn more about what we offer on the LTI websiteFind out how you can Customize your LTI experienceRelated Podcast for PatientsHealing at the Speed of Light
Dr. Rountree explains a new study from August 2021 in which they tested the effectiveness of laser therapy with wound dressing vs only wound dressing for chronic wound healing. Chronic wounds include: chronic ulcers, post-operative infections, diabetic foot ulcers, bed sores, severe burns, venous leg ulcers, and traumatic wounds. Is it possible that laser therapy can help expedite the healing process of chronic wounds? Study mentioned in this episode:Clinical effects of high-intensity laser therapy on patients with chronic refractory wounds: a randomized controlled trialVisit the LTI website for more information and to find a laser therapy provider near you.Are you a healthcare provider?Laser Therapy Institute Podcast
Cam Ayala 32 year-old, Houston native, Cam Ayala, has held many titles such as, Son, Brother, Friend, Colleague, Salesman, Account Executive, Senior Class President, Ex-Boyfriend, “ABC..Always Be Cam” from The Bachelorette and Bachelor in Paradise, but the one title that he wears with the most pride… Primary Lymphedema Patient. In April 2019, Cam Ayala became the first male Celebrity Ambassador for a New York-based global non-profit called L.E.&R.N (Lymphatic Education & Research Network). From there, he began his new professional career as a Compression Therapy Consultant, educating doctors, researchers, and patients with Lymphedema, Chronic Venous Insufficiency, and Chronic Wounds. Before I became a compression therapy consultant with Lympha Press, I was a Lympha Press patient!After being offered positions with other compression garment and compression pump companies, I decided to work for Lympha Press because I have experienced the most benefits from this device so I wanted to make that my professional and personal mission, to bring hope and relieve to as many lymphedema patients as possible that can/will benefit from Lympha Press.IG: @camronayalaFB: @cameron AyalaIf you struggle with lymphedema.https://medsolsupplier.com/contact-us/JOIN THE REVOLUTION!Join our community on facebook at The Obesity Revolution Support Group.https://www.facebook.com/groups/theobesityrevolutionJoin our movement at theobesityrevolution.com